- Issuer ticker
-
RARE
- Reported as of
-
15 Jun 2026
- Net transaction value
-
-$50,100
- SEC form
-
4
- Accepted by SEC
-
15 Jun 2026, 18:50:54 UTC
Filing notes and source
Key filing fact
Corazon (corsee) D. Sanders filed Form 4 for Ultragenyx Pharmaceutical Inc. (RARE) on 15 Jun 2026.
Key facts
- This page summarizes Corazon (corsee) D. Sanders's Form 4 filing for Ultragenyx Pharmaceutical Inc. (RARE).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 Jun 2026, 18:50.
Change
- Previous filing in this sequence was filed on 27 May 2026.
- Current net transaction value: -$50,100.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001796536
Primary reporting owner
Sanders Corazon (Corsee) D.
- Relationship
-
Director
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RARE
transaction
Common Stock
Sale
- Transaction value
- -$50,100
- Shares
- -2,000
- Change %
- -8.7%
- Price
-
$25.05
- Shares after
- 21,095
- Date
- 15 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote